{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:52:17Z","timestamp":1781491937009,"version":"3.54.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72574179"],"award-info":[{"award-number":["72574179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025\u201306\u2013199"],"award-info":[{"award-number":["320.6750.2025\u201306\u2013199"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03183-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:26:01Z","timestamp":1777371961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for intensive care unit coronavirus disease 2019 pneumonia-associated invasive fungal infections: a Bayesian evidence synthesis integrating external and real-world data"],"prefix":"10.1186","volume":"23","author":[{"given":"Chengyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-8969","authenticated-orcid":false,"given":"Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"3183_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","volume":"12","author":"S Feys","year":"2024","unstructured":"Feys S, Carvalho A, Clancy CJ, Gangneux J, Hoenigl M, Lagrou K, et al. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir Med. 2024;12:728\u201342. https:\/\/doi.org\/10.1016\/S2213-2600(24)00151-6.","journal-title":"Lancet Respir Med"},{"key":"3183_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","volume":"12","author":"F Gioia","year":"2024","unstructured":"Gioia F, Walti LN, Orchanian-Cheff A, Husain S. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Lancet Respir Med. 2024;12:207\u201316. https:\/\/doi.org\/10.1016\/S2213-2600(23)00408-3.","journal-title":"Lancet Respir Med"},{"key":"3183_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00686-4","volume":"10","author":"L Rutsaert","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020;10:71. https:\/\/doi.org\/10.1186\/s13613-020-00686-4.","journal-title":"Ann Intensive Care"},{"key":"3183_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani J. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect. 2020;1706. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.010.","journal-title":"Clin Microbiol Infect"},{"key":"3183_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garcia","year":"2021","unstructured":"Salmanton-Garcia J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, et al. COVID-19-associated pulmonary aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27:1077\u201386. https:\/\/doi.org\/10.3201\/eid2704.204895.","journal-title":"Emerg Infect Dis"},{"key":"3183_CR6","doi-asserted-by":"publisher","first-page":"e13687","DOI":"10.1111\/myc.13687","volume":"67","author":"S Aydin","year":"2024","unstructured":"Aydin S, Mert A, Yilmaz M, Al Maslamani M, Rahimi BA, Ayoade F, El-Kholy A, Belitova M, Sengel BE, Jalal S, et al. Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemia. Mycoses. 2024;67:e13687. https:\/\/doi.org\/10.1111\/myc.13687.","journal-title":"Mycoses"},{"key":"3183_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0112-2020","volume":"16","author":"CC Dobler","year":"2020","unstructured":"Dobler CC. Poor quality research and clinical practice during COVID-19. Breathe. 2020;200112. https:\/\/doi.org\/10.1183\/20734735.0112-2020.","journal-title":"Breathe"},{"key":"3183_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MCC.0000000000000977","volume":"28","author":"A Rouz\u00e9","year":"2022","unstructured":"Rouz\u00e9 A, Martin-Loeches I, Nseir S. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection? Curr Opin Crit Care. 2022;28:470\u20139. https:\/\/doi.org\/10.1097\/MCC.0000000000000977.","journal-title":"Curr Opin Crit Care"},{"key":"3183_CR9","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3758\/s13428-024-02350-2","volume":"56","author":"E van Wonderen","year":"2024","unstructured":"van Wonderen E, Zondervan-Zwijnenburg M, Klugkist I. Bayesian evidence synthesis as a flexible alternative to meta-analysis: a simulation study and empirical demonstration. Behav Res Methods. 2024;56:4085\u2013102. https:\/\/doi.org\/10.3758\/s13428-024-02350-2.","journal-title":"Behav Res Methods"},{"key":"3183_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"3183_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, the Mycoses Study Group Education and Research Consortium. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;71:1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"3183_CR12","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Florl C, Oladele RO, Vinh DC, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"key":"3183_CR13","doi-asserted-by":"publisher","first-page":"ofab452","DOI":"10.1093\/ofid\/ofab452","volume":"8","author":"E Rajni","year":"2021","unstructured":"Rajni E, Singh A, Tarai B, Jain K, Shankar R, Pawar K, Mamoria V, Chowdhary AA. High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study. Open Forum Infect Dis. 2021;8:ofab452. https:\/\/doi.org\/10.1093\/ofid\/ofab452.","journal-title":"Open Forum Infect Dis"},{"key":"3183_CR14","doi-asserted-by":"publisher","first-page":"1382720","DOI":"10.3389\/fcimb.2024.1382720","volume":"14","author":"L Su","year":"2024","unstructured":"Su L, Yu T, Zhang C, Huo P, Zhao Z. A prediction model for secondary invasive fungal infection among severe SARS-CoV-2 positive patients in ICU. Front Cell Infect Microbiol. 2024;14:1382720. https:\/\/doi.org\/10.3389\/fcimb.2024.1382720.","journal-title":"Front Cell Infect Microbiol"},{"key":"3183_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/myc.13466","volume":"65","author":"B Er","year":"2022","unstructured":"Er B, Er AG, G\u00fclmez D, _ahin TK, Hala\u00e7l\u0131 B, Durhan G, Ersoy EO, Alp A, Metan G, Saribas Z, et al. A screening study for COVID-19\u2010associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic. Mycoses. 2022;65:724\u201332. https:\/\/doi.org\/10.1111\/myc.13466.","journal-title":"Mycoses"},{"key":"3183_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad155","author":"N Permpalung","year":"2023","unstructured":"Permpalung N, Chiang TPY, Avery RK, Ostrander D, Datta K, Segev DL, et al. Coronavirus Disease 2019\u2013associated pulmonary aspergillosis: A noninvasive screening model for additional diagnostics. Open Forum Infect Dis. 2023. https:\/\/doi.org\/10.1093\/ofid\/ofad155.","journal-title":"Open Forum Infect Dis"},{"key":"3183_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03902-8","volume":"26","author":"R Leistner","year":"2022","unstructured":"Leistner R, Schroeter L, Adam T, Poddubnyy D, Stegemann M, Siegmund B, et al. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients. Crit Care. 2022;30. https:\/\/doi.org\/10.1186\/s13054-022-03902-8.","journal-title":"Crit Care"},{"key":"3183_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10051011","volume":"10","author":"F Allaw","year":"2022","unstructured":"Allaw F, Haddad SF, Habib N, Moukarzel P, Naji NS, Kanafani ZA, et al. COVID-19 and C. auris: A case-control study from a tertiary care center in Lebanon. Microorganisms. 2022;1011. https:\/\/doi.org\/10.3390\/microorganisms10051011.","journal-title":"Microorganisms"},{"key":"3183_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01296-0","volume":"14","author":"P Bay","year":"2024","unstructured":"Bay P, Audureau E, Pr\u00e9au S, Favory R, Guigon A, Heming N, et al. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. Ann Intensive Care. 2024;65. https:\/\/doi.org\/10.1186\/s13613-024-01296-0.","journal-title":"Ann Intensive Care"},{"key":"3183_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/myc.13433","volume":"65","author":"JN de Almeida","year":"2022","unstructured":"de Almeida JN, Doi AM, Watanabe MJL, Maluf MM, Calderon CL, Silva M, Pasternak J, Koga PCM, Santiago KAS, Aranha LFC, et al. COVID-19\u2010associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes. Mycoses. 2022;65:449\u201357. https:\/\/doi.org\/10.1111\/myc.13433.","journal-title":"Mycoses"},{"key":"3183_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/mmy\/myab009","volume":"59","author":"M Velez Pintado","year":"2021","unstructured":"Velez Pintado M, Camiro-Zuniga A, Aguilar Soto M, Cuenca D, Mercado M, Crabtree-Ramirez B. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Med Mycol. 2021;59:828\u201333. https:\/\/doi.org\/10.1093\/mmy\/myab009.","journal-title":"Med Mycol"},{"key":"3183_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/myc.13434","volume":"65","author":"J Calderon-Parra","year":"2022","unstructured":"Calderon-Parra J, Mills-Sanchez P, Moreno-Torres V, Tejado-Bravo S, Romero-Sanchez I, Balandin-Moreno B, Calvo-Salvador M, Portero-Azorin F, Garcia-Masedo S, Munez-Rubio E, et al. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients. Mycoses. 2022;65:541\u201350. https:\/\/doi.org\/10.1111\/myc.13434.","journal-title":"Mycoses"},{"key":"3183_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/thorax-2023-220002","volume":"79","author":"W Hurt","year":"2024","unstructured":"Hurt W, Youngs J, Ball J, Edgeworth J, Hopkins P, Jenkins DR, Leaver S, Mazzella A, Molloy SF, Schelenz S, et al. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: A prospective, multicentre UK study. Thorax. 2024;79:75\u201382. https:\/\/doi.org\/10.1136\/thorax-2023-220002.","journal-title":"Thorax"},{"key":"3183_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01229-3","author":"L Desmedt","year":"2024","unstructured":"Desmedt L, Raymond M, Le Thuaut A, Asfar P, Darreau C, Reizine F, et al. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID). Ann Intensive Care. 2024. https:\/\/doi.org\/10.1186\/s13613-023-01229-3.","journal-title":"Ann Intensive Care"},{"key":"3183_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/atm.atm_14_23","volume":"18","author":"K Ouranos","year":"2023","unstructured":"Ouranos K, Tsakiri K, Massa E, Dourliou V, Mouratidou C, Soundoulounaki S, Mouloudi E. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece. Ann Thorac Med. 2023;18:116\u201323. https:\/\/doi.org\/10.4103\/atm.atm_14_23.","journal-title":"Ann Thorac Med"},{"key":"3183_CR26","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.jfma.2022.07.006","volume":"121","author":"J Huang","year":"2022","unstructured":"Huang J, Shen H, Sun C, Chen W, Chen Y, Feng J, Yang K. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding. J Formos Med Assoc. 2022;121:2617\u201325. https:\/\/doi.org\/10.1016\/j.jfma.2022.07.006.","journal-title":"J Formos Med Assoc"},{"key":"3183_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.eimc.2024.08.007","volume":"43","author":"J De Mart\u00ednez","year":"2025","unstructured":"De Mart\u00ednez J, Fern\u00e1ndez Reyes D, de Salazar Gonz\u00e1lez A, Montero Alonso M\u00c1, Fern\u00e1ndez Morales P, Garc\u00eda Garc\u00eda F, Garc\u00eda Garc\u00eda F, Yuste Ossorio E, Hern\u00e1ndez Quero J, Guirao Arrabal E. Effects of COVID-19-Associated Pulmonary Aspergillosis (CAPA) on the prognosis of severe COVID-19: Clinical characteristics and risk factors in a second-level hospital from Southern Spain. Enfermedades infecciosas y microbiolog\u00eda cl\u00ednica. 2025;43:464\u201375. https:\/\/doi.org\/10.1016\/j.eimc.2024.08.007.","journal-title":"Enfermedades infecciosas y microbiolog\u00eda cl\u00ednica"},{"key":"3183_CR28","doi-asserted-by":"publisher","first-page":"E3606","DOI":"10.1093\/cid\/ciaa1065","volume":"73","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G, Francalanci E, et al. Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study. Clin Infect Dis. 2021;73:E3606\u201314. https:\/\/doi.org\/10.1093\/cid\/ciaa1065.","journal-title":"Clin Infect Dis"},{"key":"3183_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12879-023-08226-8","volume":"23","author":"EM Negm","year":"2023","unstructured":"Negm EM, Mohamed MS, Rabie RA, Fouad WS, Beniamen A, Mosallem A, Tawfik AE, Salama HM. Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country. BMC Infect Dis. 2023;23:211\u201346. https:\/\/doi.org\/10.1186\/s12879-023-08226-8.","journal-title":"BMC Infect Dis"},{"key":"3183_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"J Gangneux","year":"2022","unstructured":"Gangneux J, Dannaoui E, Fekkar A, Luyt C, Botterel F, De Prost N, Tadie J, Reizine F, Houze S, Timsit J, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Resp Med. 2022;10:180\u201390. https:\/\/doi.org\/10.1016\/S2213-2600(21)00442-2.","journal-title":"Lancet Resp Med"},{"key":"3183_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jof9050583","author":"CM Roman-Montes","year":"2023","unstructured":"Roman-Montes CM, Bojorges-Aguilar S, Corral-Herrera EA, Rangel-Cordero A, Diaz-Lomeli P, Cervantes-Sanchez A, et al. Fungal infections in the ICU during the COVID-19 pandemic in Mexico. J Fungi. 2023. https:\/\/doi.org\/10.3390\/jof9050583.","journal-title":"J Fungi"},{"key":"3183_CR32","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/jmv.26633","volume":"93","author":"E Bishburg","year":"2021","unstructured":"Bishburg E, Okoh A, Nagarakanti SR, Lindner M, Migliore C, Patel P. Fungemia in COVID-19 ICU patients, a single medical center experience. J Med Virol. 2021;93:2810\u20134. https:\/\/doi.org\/10.1002\/jmv.26633.","journal-title":"J Med Virol"},{"key":"3183_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/cid\/ciad546","volume":"78","author":"S Feys","year":"2024","unstructured":"Feys S, Lagrou K, Lauwers HM, Haenen K, Jacobs C, Brusselmans M, Debaveye Y, Hermans G, Hoenigl M, Maertens J, et al. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation. Clin Infect Dis. 2024;78:361\u201370. https:\/\/doi.org\/10.1093\/cid\/ciad546.","journal-title":"Clin Infect Dis"},{"key":"3183_CR34","doi-asserted-by":"publisher","first-page":"e13773","DOI":"10.1111\/myc.13773","volume":"67","author":"W Imoto","year":"2024","unstructured":"Imoto W, Ihara Y, Imai T, Kawai R, Yamada K, Kaneko Y, Shintani A, Kakeya H. Incidence and risk factors for coronavirus disease 2019-associated pulmonary aspergillosis using administrative claims data. Mycoses. 2024;67:e13773. https:\/\/doi.org\/10.1111\/myc.13773.","journal-title":"Mycoses"},{"key":"3183_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154272","volume":"76","author":"R van Grootveld","year":"2023","unstructured":"van Grootveld R, van der Beek MT, Janssen NAF, Erg\u00fcn M, van Dijk K, Bethlehem C, et al. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy. J Crit Care. 2023;154272. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154272.","journal-title":"J Crit Care"},{"key":"3183_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154004","author":"O Ayalon","year":"2022","unstructured":"Ayalon O, Cohen MJ, Orenbuch-Harroch E, Sviri S, van Heerden PV, Korem M. Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel. J Crit Care. 2022. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154004.","journal-title":"J Crit Care"},{"key":"3183_CR37","doi-asserted-by":"publisher","first-page":"e0238825","DOI":"10.1371\/journal.pone.0238825","volume":"16","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, Rothe K, Spinner CD, Schneider J, Mayer U, Neuenhahn M, Hoffmann D, Geisler F, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study. PLoS ONE. 2021;16:e0238825. https:\/\/doi.org\/10.1371\/journal.pone.0238825.","journal-title":"PLoS ONE"},{"key":"3183_CR38","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3201\/eid2711.211174","volume":"27","author":"NAF Janssen","year":"2021","unstructured":"Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Erg\u00fcn M, Buil JB, Van Dijk K, Altenburg J, Bouman CSC, Van der Spoel HI, et al. Multinational observational cohort study of covid-19-associated pulmonary aspergillosis. Emerg Infect Dis. 2021;27:2892\u20138. https:\/\/doi.org\/10.3201\/eid2711.211174.","journal-title":"Emerg Infect Dis"},{"key":"3183_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/myc.13485","volume":"65","author":"Z Hashim","year":"2022","unstructured":"Hashim Z, Nath A, Khan A, Neyaz Z, Marak RSK, Areekkara P, Tiwari A, Srivastava S, Agarwal V, Saxena S, et al. New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients. Mycoses. 2022;65:1010\u201323. https:\/\/doi.org\/10.1111\/myc.13485.","journal-title":"Mycoses"},{"key":"3183_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin J, Marcelin A, Monsel A, Luyt C, Blaize M. Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU. Am J Respir Crit Care Med. 2021;203:307\u201317. https:\/\/doi.org\/10.1164\/rccm.202009-3400OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3183_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jof9030315","author":"F Bergmann","year":"2023","unstructured":"Bergmann F, Jorda A, Blaschke A, Gabler C, Bohdan S, Nussbaumer-Proll A, et al. Pulmonary aspergillosis in critically ill COVID-19 patients admitted to the intensive care unit: a retrospective cohort study. J Fungi. 2023. https:\/\/doi.org\/10.3390\/jof9030315.","journal-title":"J Fungi"},{"key":"3183_CR42","doi-asserted-by":"publisher","unstructured":"Bentvelsen RG, Arkel ALEV, Rijpstra TA, Kant MKM, Brugge SVDS, Loth DW, Van Wijngaarden P, Mee AWFD, Yick DCY, Diederen BMW, et al. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave. J Fungi. 2022;8. https:\/\/doi.org\/10.3390\/jof8020096.","DOI":"10.3390\/jof8020096"},{"key":"3183_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13054-024-05104-w","volume":"28","author":"F Reizine","year":"2024","unstructured":"Reizine F, Massart N, Mansour A, Fedun Y, Machut A, Vacheron C, Savey A, Friggeri A, Lepape A. Relationship between SARS-CoV-2 infection and ICU-acquired candidemia in critically ill medical patients: a multicenter prospective cohort study. Crit Care. 2024;28:320. https:\/\/doi.org\/10.1186\/s13054-024-05104-w.","journal-title":"Crit Care"},{"key":"3183_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3904\/kjim.2022.069","volume":"37","author":"R Lee","year":"2022","unstructured":"Lee R, Cho S, Lee D, Ahn H, Choi H, Choi S, Choi J, Choi J, Kim SY, Kim YJ, et al. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study. Korean J Intern Med. 2022;37:851\u201363. https:\/\/doi.org\/10.3904\/kjim.2022.069.","journal-title":"Korean J Intern Med"},{"key":"3183_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes J, Wauters J, Giacobbe DR, Salmanton-Garc\u00eda J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients\u2014a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2022;28:580\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2021.08.014.","journal-title":"Clin Microbiol Infect"},{"key":"3183_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.53854\/liim-3101-8","volume":"31","author":"G Tiseo","year":"2022","unstructured":"Tiseo G, Galfo V, Occhineri S, Forniti A, Caroselli C, Falcone M, Menichetti F. Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital. Infez Med. 2022;31:55\u201361. https:\/\/doi.org\/10.53854\/liim-3101-8.","journal-title":"Infez Med"},{"key":"3183_CR47","doi-asserted-by":"publisher","first-page":"1287496","DOI":"10.3389\/fcimb.2023.1287496","volume":"13","author":"X Zhou","year":"2023","unstructured":"Zhou X, Wu X, Chen Z, Cui X, Cai Y, Liu Y, Weng B, Zhan Q, Huang L. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA. Front Cell Infect Microbiol. 2023;13:1287496. https:\/\/doi.org\/10.3389\/fcimb.2023.1287496.","journal-title":"Front Cell Infect Microbiol"},{"key":"3183_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.005","author":"S Delliere","year":"2021","unstructured":"Delliere S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic P, et al. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2021. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.005.","journal-title":"Clin Microbiol Infect"},{"key":"3183_CR49","first-page":"1049","volume":"84","author":"ED Diaz Lobo","year":"2024","unstructured":"Diaz Lobo ED, Gomez Giglio M, Huaier Arriazu EF, Carboni Bisso IA, Las Heras MJ, Peroni ML. Risk factors associated with invasive pulmonary aspergillosis in severe COVID-19 patients: a casecontrol study. Med (B Aires). 2024;84:1049\u201360.","journal-title":"Med (B Aires)"},{"key":"3183_CR50","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e134","volume":"37","author":"SH Kim","year":"2022","unstructured":"Kim SH, Hong JY, Bae S, Lee H, Wi YM, Ko JH, et al. Risk factors for Coronavirus Disease 2019 (COVID-19)-associated pulmonary aspergillosis in critically ill patients: a nationwide, multicenter, retrospective cohort study. J Korean Med Sci. 2022;37:e134. https:\/\/doi.org\/10.3346\/jkms.2022.37.e134.","journal-title":"J Korean Med Sci"},{"key":"3183_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12879-024-09283-3","volume":"24","author":"A Iacovelli","year":"2024","unstructured":"Iacovelli A, Oliva A, Mirabelli FM, Giannone S, Laguardia M, Morviducci M, Nicolardi ML, Repaci E, Sanzari MT, Leanza C, et al. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit. BMC Infect Dis. 2024;24:314\u201392. https:\/\/doi.org\/10.1186\/s12879-024-09283-3.","journal-title":"BMC Infect Dis"},{"key":"3183_CR52","doi-asserted-by":"publisher","first-page":"753659","DOI":"10.3389\/fmed.2021.753659","volume":"8","author":"J Xu","year":"2021","unstructured":"Xu J, Yang X, Lv Z, Zhou T, Liu H, Zou X, Cao F, Zhang L, Liu B, Chen W, et al. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study. Front Med. 2021;8:753659. https:\/\/doi.org\/10.3389\/fmed.2021.753659.","journal-title":"Front Med"},{"key":"3183_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4314\/ahs.v24i4.10","volume":"24","author":"E Eryilmaz-Eren","year":"2024","unstructured":"Eryilmaz-Eren E, Sav H, Ozer-Simsek Z, Ozcan I, Kilinc-Toker A, Kanat A, Cetinkaya A, Yuksel RC, Aydin K, Guzeldag S, et al. Risk factors for invasive mold infection after COVID-19: case-control study. Afr Health Sci. 2024;24:77\u201384. https:\/\/doi.org\/10.4314\/ahs.v24i4.10.","journal-title":"Afr Health Sci"},{"key":"3183_CR54","unstructured":"Wang Y. Analysis of Risk Factors for Severe Coronavirus Disease 2019 Complicated with Invasive. Pulmonary Aspergillosis; Henan University; 2024."},{"key":"3183_CR55","doi-asserted-by":"publisher","first-page":"ofad062","DOI":"10.1093\/ofid\/ofad062","volume":"10","author":"M Shah","year":"2023","unstructured":"Shah M, Reveles K, Moote R, Hand E, Kellogg Iii D, Attridge RL, Maselli DJ, Gutierrez GC. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients. Open Forum Infect Dis. 2023;10:ofad062. https:\/\/doi.org\/10.1093\/ofid\/ofad062.","journal-title":"Open Forum Infect Dis"},{"key":"3183_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"J Gangneux","year":"2022","unstructured":"Gangneux J, Dannaoui E, Fekkar A, Luyt C, Botterel F, De Prost N, Tadie J, Reizine F, Houze S, Timsit J, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Resp Med. 2022;10:180\u201390. https:\/\/doi.org\/10.1016\/S2213-2600(21)00442-2.","journal-title":"Lancet Resp Med"},{"key":"3183_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7:1127\u201340. https:\/\/doi.org\/10.1038\/s41564-022-01172-2.","journal-title":"Nat Microbiol"},{"key":"3183_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/jof9060667","volume":"9","author":"KM Hlaing","year":"2023","unstructured":"Hlaing KM, Monday LM, Nucci M, Nou\u00e9r SA, Revankar SG. Invasive fungal infections associated with COVID-19. J Fungi. 2023;9:667. https:\/\/doi.org\/10.3390\/jof9060667.","journal-title":"J Fungi"},{"key":"3183_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211043413","volume":"49","author":"M Zia","year":"2021","unstructured":"Zia M, Goli M. Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article. J Int Med Res. 2021;49:3000605211043413. https:\/\/doi.org\/10.1177\/03000605211043413.","journal-title":"J Int Med Res"},{"key":"3183_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15010-021-01701-x","volume":"50","author":"WH Chong","year":"2022","unstructured":"Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection. 2022;50:43\u201356. https:\/\/doi.org\/10.1007\/s15010-021-01701-x.","journal-title":"Infection"},{"key":"3183_CR61","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s43587-021-00114-7","volume":"1","author":"JM Bartleson","year":"2021","unstructured":"Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the aging immune system. Nat Aging. 2021;1:769\u201382. https:\/\/doi.org\/10.1038\/s43587-021-00114-7.","journal-title":"Nat Aging"},{"key":"3183_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315\u201320. https:\/\/doi.org\/10.1038\/s41586-020-2700-3.","journal-title":"Nature"},{"key":"3183_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010076","author":"CF Rodrigues","year":"2019","unstructured":"Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8010076.","journal-title":"J Clin Med"},{"key":"3183_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01259-8","volume":"20","author":"EE Hammond","year":"2020","unstructured":"Hammond EE, Mcdonald CS, Vestbo J, Denning DW. The global impact of Aspergillus infection on COPD. BMC Pulm Med. 2020;20:241. https:\/\/doi.org\/10.1186\/s12890-020-01259-8.","journal-title":"BMC Pulm Med"},{"key":"3183_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","volume":"26","author":"M Syed-Ahmed","year":"2019","unstructured":"Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26:8\u201315. https:\/\/doi.org\/10.1053\/j.ackd.2019.01.004.","journal-title":"Adv Chronic Kidney Dis"},{"key":"3183_CR66","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00134-025-07797-1","volume":"51","author":"O Epelbaum","year":"2025","unstructured":"Epelbaum O, de Moraes AG, Olson JC, Lionakis MS. Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit. Intensive Care Med. 2025;51:364\u201377. https:\/\/doi.org\/10.1007\/s00134-025-07797-1.","journal-title":"Intensive Care Med"},{"key":"3183_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac037","volume":"9","author":"G Satyanarayana","year":"2022","unstructured":"Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, et al. Coinfections in patients with cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) study. Open Forum Infect Dis. 2022;9:ofac037. https:\/\/doi.org\/10.1093\/ofid\/ofac037.","journal-title":"Open Forum Infect Dis"},{"key":"3183_CR68","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/ijccm.IJCCM_181_18","volume":"22","author":"A Chakraborti","year":"2018","unstructured":"Chakraborti A, Jaiswal A, Verma PK, Singhal RA. Prospective study of fungal colonization and invasive fungal disease in long-term mechanically ventilated patients in a respiratory intensive care unit. Indian J Crit Care Med. 2018;22:597\u2013601. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_181_18.","journal-title":"Indian J Crit Care Med"},{"key":"3183_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04272-3","volume":"26","author":"D Quickfall","year":"2025","unstructured":"Quickfall D, La A, Pisano J, Costello P, Gunning S, Koyner JL. Infections and mortality in ICU patients undergoing continuous renal replacement therapy: a retrospective cohort study. BMC Nephrol. 2025;26:321. https:\/\/doi.org\/10.1186\/s12882-025-04272-3.","journal-title":"BMC Nephrol"},{"key":"3183_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/jof9050583","volume":"9","author":"CM Roman-Montes","year":"2023","unstructured":"Roman-Montes CM, Bojorges-Aguilar S, Corral-Herrera EA, Rangel-Cordero A, D\u00edaz-Lomel\u00ed P, Cervantes-Sanchez A, et al. Fungal infections in the ICU during the COVID-19 pandemic in Mexico. J Fungi. 2023;9:583. https:\/\/doi.org\/10.3390\/jof9050583.","journal-title":"J Fungi"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03183-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:00:12Z","timestamp":1781488812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03183-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived for this study because it was a retrospective analysis using existing clinical data. No interventions were performed on the patients, and no biological samples were collected. Publication of the study does not disclose any personal information of the patients. The study posed no more than minimal risk, and waiving informed consent does not affect the rights or health of the patients. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Xi\u2019an Jiaotong University (Approval No.: 2025\u2013027).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}